Add Yahoo as a preferred source to see more of our stories on Google. It's important to approach this situation with a sense of calm and a lack of judgment. LordHenriVoton via Getty Images Being in a ...
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small ...
At the American Society of Clinical Oncology (ASCO) meeting, new subgroup and real-world analyses added to the growing ...
Among patients with relapsed or refractory multiple myeloma who had previously received at least one line of therapy, ...
Transcription: Colleen Moretti: What is relapsed/refractory multiple myeloma? How does it differ from typical disease? Dr. Saad Usmani: Relapsed and/or refractory myeloma is myeloma that has come back ...
Incyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for Adults with Relapsed or ...
Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 protein only after treatment with chemotherapy, allowing them to survive by ...
Flavor Flav is owning up to his mistakes — and moving forward. On Thursday, the Public Enemy rapper revealed that he recently relapsed after more than four years of sobriety, but shared his commitment ...
Johnson & Johnson has welcomed the Scottish Medicines Consortium’s decision to accept Talvey (talquetamab) for use within NHS ...
Evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) to inform the management of patients (pts) treated with teclistamab in MajesTEC-1. This is an ASCO ...
KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results